This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Kevin Kimura
Introduction
Kevin Kimura is a notable inventor based in Seattle, WA, recognized for his pioneering work in the field of nucleic acid amplification technologies. His research has significantly advanced the methods of concentrating and amplifying nucleic acids, focusing on the integration of isotachophoresis with isothermal amplification techniques.
Latest Patents
Kevin Kimura holds a patent for "Isotachophoresis Enhanced Isothermal Nucleic Acid Amplification." This innovative patent discloses a method that enhances the concentration and amplification of nucleic acids using an isotachophoresis device. The device features a porous matrix and first and second electrodes, along with specific electrolytes and amplification reaction reagents. By applying a voltage across the electrodes, the method successfully creates an isotachophoresis (ITP) plug with a nucleic acid concentration significantly higher than that in the surrounding fluids.
Career Highlights
Kevin's commitment to innovation is evident through his work at the University of Washington, where he contributes to advancing scientific research in molecular biology. His invention aids in improving the efficiency of nucleic acid analysis, which can have profound implications in diagnostics, forensics, and research.
Collaborations
In his journey of innovation, Kevin has collaborated with esteemed colleagues such as Jonathan Posner and Mark D. Borysiak. Their collective expertise has not only enriched the quality of their research but has also fostered a collaborative environment that encourages creative problem-solving and technological advancements.
Conclusion
Kevin Kimura's work exemplifies the spirit of innovation in the scientific community. His patent is a testament to his dedication to enhancing nucleic acid amplification techniques, making significant strides in the field. As he continues his research, his contributions are likely to lead to further advancements that will benefit various applications in biology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile